The Open University
Characterization of Lipid Bioenergetic Markers in Alzheimer's Disease (AD) in Apolipoprotein E4 (<i>APOE</i>) and non-E4 Carriers.
Abstract
dc:description.abstractAlzheimer’s disease (AD) is a progressive neurodegenerative disease of ageing with an estimated prevalence of 36 million worldwide. Individuals carrying one ε4 allele of the apolipoprotein E gene (<i>APOE</i>) are 6 times more likely to develop AD than ε3 homozygotes. Further, ε4 carriers have an abnormal increased reliance on fatty acid oxidation (FAO). The L-carnitine system consisting of L-carnitine and its esters (acylcarnitines) plays an important role in FAO. We therefore hypothesized that changes in blood and brain levels of L-carnitine, its metabolites (TMAO and GBB) as well as acylcarnitines would be indicative of dysfunctional FAO in ageing ε4 carriers influencing AD onset and progression. The L-carnitine system was evaluated in blood and brain in association with <i>APOE</i> in multiple cohorts of controls and patients over the continuum of AD. To investigate the influence of age and <i>APOE</i> on this system a mouse model of AD with human <i>APOE</i> was examined. In this model <i>ex vivo</i> cerebrovascular uptake of L-carnitine metabolites and fatty acids (FAs) were also investigated in relation to <i>APOE</i>. Additionally, a 1-week L-carnitine oral challenge was performed to evaluate the influence of <i>APOE</i> on L-carnitine metabolism. These data suggested that the L-carnitine pathway is dysregulated early on in AD, particularly among ε4 carriers. In the brain, changes in the L-carnitine system were related to AD pathology in an <i>APOE</i>-dependent manner. In mouse models <i>APOE</i> did not affect cerebrovascular uptake of L-carnitine metabolites and FAs or the metabolism of L-carnitine after oral challenge. However, acylcarnitines were differentially affected in different genotypes after cerebrovascular uptake of compounds and L-carnitine challenge suggesting altered in FAO flux in different <i>APOE</i> genotypes. <br></br><br></br> Understanding disturbances in the L-carnitine system with age, in relation to <i>APOE</i> genotypes, and their collective contributions to AD will help develop targeted prevention and therapeutic strategies.
Degree
thesis:*- Name dc:type.qualificationname
- phd
- Level dc:type.qualificationlevel
- doctoral
- Grantor dc:publisher.institution
- The Open University
- Year dc:date.issued
- 2022
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Huguenard, Claire J. C.
Rights
- Language dc:language
- en